Zhang, Jianglin <br/><br/>
Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.  [electronic resource] 

 -  Oncotarget  Nov 2016 
 - 79557-79571 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.12836  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--chemistry<br/>Catechin--analogs & derivatives<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Gene Expression Regulation, Neoplastic<br/>HEK293 Cells<br/>Humans<br/>Intracellular Signaling Peptides and Proteins<br/>Lung Neoplasms--genetics<br/>MAP Kinase Kinase Kinases--metabolism<br/>Melanoma--drug therapy<br/>Mice, Inbred BALB C<br/>Molecular Docking Simulation<br/>NF-KappaB Inhibitor alpha--metabolism<br/>NF-kappa B--metabolism<br/>Neoplasm Invasiveness<br/>Phosphorylation<br/>Protein Binding<br/>Protein Conformation<br/>Signal Transduction<br/>Skin Neoplasms--drug therapy<br/>Structure-Activity Relationship<br/>TNF Receptor-Associated Factor 6--antagonists & inhibitors<br/>Transfection<br/>Tumor Burden--drug effects<br/>Ubiquitin-Conjugating Enzymes--metabolism<br/>Ubiquitin-Protein Ligases--antagonists & inhibitors<br/>Ubiquitination